COAG — HEMAB THERAPEUTICS HLDGS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 59 SEC-registered investment managers reported holding COAG (HEMAB THERAPEUTICS HLDGS INC) in their latest 13F filings, with a combined reported value of $1.34B across 37.36M shares. Ownership is concentrated: the five largest holders account for 62.5% of reported value and the top ten for 83.3%.
Compared with the prior quarter, 59 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of HEMAB THERAPEUTICS HLDGS INC (COAG) include RA CAPITAL MANAGEMENT, L.P., Novo Holdings A/S, Deep Track Capital, LP, ranked by reported 13F value among the 89 institutional holders on this page.
COAG is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 49 | 15.64M | $484.21M | +14.9% |
| Q2 2026 | 59 | 37.36M | $1.34B | — |
| Q2 2025 | 1 | 600 | $2.00K | — |
| Q1 2025 | 1 | 300 | $1.33K | -57.1% |
| Q4 2024 | 2 | 900 | $6.48K | -65.4% |
| Q3 2024 | 2 | 2.60K | $33.26K | -67.1% |
| Q2 2024 | 2 | 7.90K | $95.14K | -4.8% |
| Q1 2024 | 2 | 8.30K | $134.57K | — |
Over the 8 quarters shown, institutional share counts increased 188394% in aggregate (Q1 2024 → Q3 2026); the largest single-quarter swing was Q3 2024 (-67.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.72M | $114.80M | 0.01% | Add | |
| 3.60M | $111.07M | 0.02% | Hold | |
| 2.37M | $72.97M | 1.73% | Add | |
| 1.40M | $43.15M | 0.00% | Add | |
| 932.86K | $30.41M | 0.00% | Reduce | |
| 927.25K | $28.60M | 0.00% | New | |
| 774.06K | $23.87M | 0.00% | Reduce | |
| 502.04K | $15.49M | 0.00% | Add | |
| 420.00K | $12.95M | 0.60% | Add | |
| 137.14K | $4.23M | 0.00% | Add | |
| 124.79K | $3.85M | 0.00% | Add | |
| 106.66K | $3.29M | 0.00% | Add | |
| 96.45K | $2.97M | 0.01% | Reduce | |
| 67.54K | $2.08M | 0.00% | New | |
| 50.42K | $1.55M | 0.01% | New | |
| 45.36K | $1.40M | 0.00% | New | |
| 33.10K | $1.08M | 0.00% | Hold | |
| 30.70K | $946.79K | 0.00% | New | |
| 30.14K | $929.42K | 0.00% | Add | |
| 29.39K | $906.29K | 0.00% | New | |
| 28.64K | $883.38K | 0.00% | New | |
| 24.43K | $753.36K | 0.00% | Add | |
| 22.35K | $689.24K | 0.00% | New | |
| 21.63K | $667.16K | 0.00% | New | |
| 17.98K | $554.47K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 7.81M | $286.81M | 2.49% | New | |
| 4.18M | $153.55M | 8.92% | New | |
| 3.70M | $135.82M | 0.01% | New | |
| 3.60M | $132.37M | 0.03% | New | |
| 3.60M | $132.30M | 1.97% | New | |
| 2.09M | $76.65M | 1.56% | New | |
| 1.93M | $70.71M | 0.64% | New | |
| 1.65M | $60.60M | 3.60% | New | |
| 1.15M | $42.33M | 0.01% | New | |
| 780.76K | $28.68M | 0.00% | New | |
| 746.04K | $27.40M | 0.00% | New | |
| 715.79K | $26.29M | 0.15% | New | |
| 575.43K | $21.14M | 1.03% | New | |
| 550.00K | $20.20M | 0.42% | New | |
| 523.45K | $19.23M | 0.02% | New | |
| 283.83K | $10.43M | 0.00% | New | |
| 275.00K | $10.10M | 0.13% | New | |
| 218.29K | $8.02M | 0.09% | New | |
| 211.80K | $7.78M | 0.00% | New | |
| 211.80K | $7.78M | 0.00% | New | |
| 160.00K | $5.88M | 0.23% | New | |
| 154.67K | $5.68M | 0.01% | New | |
| 150.04K | $5.51M | 0.02% | New | |
| 138.03K | $5.07M | 0.24% | New | |
| 115.39K | $4.24M | 0.01% | New |
Q2 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 600 | $2.00K | 0.00% | New |
Q1 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 300 | $1.33K | 0.00% | Reduce |
Q4 2024 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 700 | $5.48K | 0.00% | Add | |
| 200 | $1.00K | 0.00% | Reduce |
Q3 2024 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.20K | $28.00K | 0.00% | Add | |
| 400 | $5.26K | 0.00% | Reduce |
New Positions (Q2 2026)
- RA CAPITAL MANAGEMENT, L.P. 7.81M sh · $286.81M
- Novo Holdings A/S 4.18M sh · $153.55M
- Fidelity Management & Research (FMR) 3.70M sh · $135.82M
- Capital International Investors 3.60M sh · $132.37M
- Deep Track Capital, LP 3.60M sh · $132.30M
- Siren, L.L.C. 2.09M sh · $76.65M
- Avoro Capital Advisors LLC 1.93M sh · $70.71M
- Bain Capital Life Sciences Investors, LLC 1.65M sh · $60.60M
- JPMorgan Chase & Co 1.15M sh · $42.33M
- VANGUARD CAPITAL MANAGEMENT LLC 780.76K sh · $28.68M
- PRICE T ROWE ASSOCIATES INC /MD/ 746.04K sh · $27.40M
- DRIEHAUS CAPITAL MANAGEMENT LLC 715.79K sh · $26.29M
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 3.72M | 3.70M | — | — | — | — | — | — |
| Capital International Investors | 3.60M | 3.60M | — | — | — | — | — | — |
| Siren, L.L.C. | 2.37M | 2.09M | — | — | — | — | — | — |
| BlackRock Inc | 1.40M | 283.83K | — | — | — | — | — | — |
| JPMorgan Chase & Co | 932.86K | 1.15M | — | — | — | — | — | — |
| STATE STREET CORP | 927.25K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 774.06K | 780.76K | — | — | — | — | — | — |
| Geode Capital Management | 502.04K | 211.80K | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 420.00K | 138.03K | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 137.14K | 8.17K | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 124.79K | 112.50K | — | — | — | — | — | — |
| UBS Group AG | 106.66K | 47.35K | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 96.45K | 115.39K | — | — | — | — | — | — |
| Renaissance Technologies | 67.54K | — | — | — | — | — | — | — |
| Quadrature Capital Ltd | 50.42K | — | — | — | — | — | — | — |
| BNY Mellon | 45.36K | — | — | — | — | — | — | — |
| TD ASSET MANAGEMENT INC | 33.10K | 33.10K | — | — | — | — | — | — |
| Swiss National Bank | 30.70K | — | — | — | — | — | — | — |
| Morgan Stanley | 30.14K | 4.08K | — | — | — | — | — | — |
| Nuveen, LLC | 29.39K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold COAG?
As of 2026-Q2, 59 institutional funds reported holding COAG (HEMAB THERAPEUTICS HLDGS INC) in SEC 13F filings, with a combined reported value of $1.34B.
How many shares of COAG do institutions own?
13F filers reported 37.36M shares of COAG, worth $1.34B in aggregate at the end of 2026-Q2.
Is institutional ownership of COAG rising or falling?
No prior-quarter baseline is available for a directional read.
Who are the top institutional holders of COAG?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., Novo Holdings A/S, Deep Track Capital, LP, Fidelity Management & Research (FMR), Capital International Investors; the top 25 are ranked at the top of this page.
Who are the major shareholders of HEMAB THERAPEUTICS HLDGS INC?
The major shareholders of HEMAB THERAPEUTICS HLDGS INC (COAG) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., Novo Holdings A/S, Deep Track Capital, LP, Fidelity Management & Research (FMR), Capital International Investors, among 89 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.